Literature DB >> 24858874

Reducing barriers to hepatitis C treatment among drug users: an integrated hepatitis C peer education and support program.

Robert J Roose, Lauren Cockerham-Colas, Irene Soloway, Abigail Batchelder, Alain H Litwin.   

Abstract

This report describes an innovative HCV Peer Educator Program that facilitates education, support, and engagement in HCV treatment among patients in an opioid treatment program. Integrating peer educators in a collaborative manner with close supervision holds promise as a model to reduce barriers to HCV treatment among drug users.

Entities:  

Mesh：

Year:  2014        PMID： 24858874      PMCID： PMC6130977          DOI： 10.1353/hpu.2014.0096

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN： 1049-2089


  15 in total

1.  Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Authors:  B R Edlin; K H Seal; J Lorvick; A H Kral; D H Ciccarone; L D Moore; B Lo
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

2.  Treatment of chronic hepatitis C in active drug users.

Authors:  G L Davis; J R Rodrigue
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

Review 3.  National Institutes of Health Consensus Development Conference statement Management of Hepatitis C: 2002 June 10-12, 2002.

Authors: 
Journal:  HIV Clin Trials       Date:  2003 Jan-Feb

Review 4.  Hepatitis C treatment for injection drug users: a review of the available evidence.

Authors:  Margaret Hellard; Rachel Sacks-Davis; Judy Gold
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

5.  Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.

Authors:  Alain H Litwin; Irene Soloway; Marc N Gourevitch
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

6.  Hepatitis C virus prevention, care, and treatment: from policy to practice.

Authors:  John W Ward; Ron O Valdiserri; Howard K Koh
Journal:  Clin Infect Dis       Date:  2012-07       Impact factor: 9.079

7.  Needle-exchange attendance and health care utilization promote entry into detoxification.

Authors:  S A Strathdee; D D Celentano; N Shah; C Lyles; V A Stambolis; G Macalino; K Nelson; D Vlahov
Journal:  J Urban Health       Date:  1999-12       Impact factor: 3.671

8.  Limited uptake of hepatitis C treatment among injection drug users.

Authors:  Shruti H Mehta; Becky L Genberg; Jacquie Astemborski; Ravi Kavasery; Gregory D Kirk; David Vlahov; Steffanie A Strathdee; David L Thomas
Journal:  J Community Health       Date:  2008-06

9.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

Authors:  Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Journal:  Gastroenterology       Date:  2009-10-25       Impact factor: 22.682

10.  Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program.

Authors:  Alain H Litwin; Kenneth A Harris; Shadi Nahvi; Philippe J Zamor; Irene J Soloway; Peter L Tenore; Daniel Kaswan; Marc N Gourevitch; Julia H Arnsten
Journal:  J Subst Abuse Treat       Date:  2008-11-28
View more
  19 in total

Review 1.  Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.

Authors:  Emma Day; Margaret Hellard; Carla Treloar; Julie Bruneau; Natasha K Martin; Anne Øvrehus; Olav Dalgard; Andrew Lloyd; John Dillon; Matt Hickman; Jude Byrne; Alain Litwin; Mojca Maticic; Philip Bruggmann; Havard Midgard; Brianna Norton; Stacey Trooskin; Jeffrey V Lazarus; Jason Grebely
Journal:  Liver Int       Date:  2018-09-22       Impact factor: 5.828

Review 2.  Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum.

Authors:  Jaimie P Meyer; Yavar Moghimi; Ruthanne Marcus; Joseph K Lim; Alain H Litwin; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2015-05-17

3.  The Hepatitis C virus treatment cascade at an urban postincarceration transitions clinic.

Authors:  L Hawks; B L Norton; C O Cunningham; A D Fox
Journal:  J Viral Hepat       Date:  2016-02-09       Impact factor: 3.728

4.  "Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment.

Authors:  A W Batchelder; D Peyser; S Nahvi; J H Arnsten; A H Litwin
Journal:  Drug Alcohol Depend       Date:  2015-06-09       Impact factor: 4.492

5.  Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Authors:  Jason Grebely; Geert Robaeys; Philip Bruggmann; Alessio Aghemo; Markus Backmund; Julie Bruneau; Jude Byrne; Olav Dalgard; Jordan J Feld; Margaret Hellard; Matthew Hickman; Achim Kautz; Alain Litwin; Andrew R Lloyd; Stefan Mauss; Maria Prins; Tracy Swan; Martin Schaefer; Lynn E Taylor; Gregory J Dore
Journal:  Int J Drug Policy       Date:  2015-07-17

Review 6.  Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice.

Authors:  Brianna L Norton; Matthew J Akiyama; Philippe J Zamor; Alain H Litwin
Journal:  Infect Dis Clin North Am       Date:  2018-06       Impact factor: 5.982

7.  Nurse case management to improve the hepatitis C care continuum in HIV co-infection: Results of a randomized controlled trial.

Authors:  Laura E Starbird; Chakra Budhathoki; Hae-Ra Han; Mark S Sulkowski; Nancy R Reynolds; Jason E Farley
Journal:  J Viral Hepat       Date:  2019-12-09       Impact factor: 3.728

8.  The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.

Authors:  Stella A Safo; Abigail Batchelder; Deena Peyser; Alain H Litwin
Journal:  Harm Reduct J       Date:  2015-06-20

Review 9.  Innovations in Hepatitis C Screening and Treatment.

Authors:  Arpan A Patel; Aileen Bui; Eian Prohl; Debika Bhattacharya; Su Wang; Andrea D Branch; Ponni V Perumalswami
Journal:  Hepatol Commun       Date:  2020-12-07

10.  Perceived benefits of the hepatitis C peer educators: a qualitative investigation.

Authors:  A W Batchelder; L Cockerham-Colas; D Peyser; S P Reynoso; I Soloway; A H Litwin
Journal:  Harm Reduct J       Date:  2017-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.